Connect with us

Hi, what are you looking for?

Stock

Chevy Bolt owners to receive settlement checks after successful class-action suit over faulty batteries

Chevy Bolt owners are eligible for settlement checks as part of a $150 million class-action settlement with General Motors and South Korean industrial group LG over faulty batteries.

According to documents filed in a Michigan court Thursday, Bolt EV owners who installed software before Dec. 31, 2023 that had been designed to fix the battery issue will be eligible to receive a check for up to $1,400. Customers who sold their Bolt or terminated their leases before the software remedy was released — or ones who received a replacement battery — will receive a $700 check at minimum.

“GM, LG Energy Solution and LG Electronics have agreed to a settlement with plaintiffs to resolve class action litigation related to the Bolt EV battery recall,” GM said in an emailed statement to Reuters.

“As a result, Bolt owners who received a battery replacement or who have installed the latest advanced diagnostic software may qualify for compensation,” the company said.

GM began recalling Bolt EVs after receiving multiple complaints about the LG-branded batteries catching fire.

The recall effort ultimately cost GM nearly $2 billion.

This post appeared first on NBC NEWS

World biggest companies

Learn Trading With Online Courses, Classes, & Lessons

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 GreatWallStreetPublisher.com